Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine

H. Lundbeck A/S (Lundbeck) today announced the acceptance of its new drug application (NDA) for Vyepti® (eptinezumab) by the Ministry of Health, Labor and Welfare (MHLW) in Japan.
PolitiFact

The Epstein files, Trump and Congress: What happens next?

In July 2019, Epstein was arrested on federal charges for recruiting dozens of underage girls to his New York City mansion and Palm Beach estate from 2002 to 2005 to engage in sex acts for money. He ...
MacStories

Picmal Streamlines Batch Conversion and Compression on the Mac

One of my favorite aspects of macOS is the endless supply of great utilities for doing anything you can imagine. If there’s ...

Make PDF headaches disappear with this $30 lifetime software deal

A lifetime license to PDF Converter & Editor is now just $29.99 — no monthly fees, no limits. Edit, convert, and secure your ...
Macworld

Turn your Mac into a PDF command center with this app, now $60 off

TL;DR: Get lifetime access to PDF Expert Premium for Mac for just $79.99 (MSRP $139.99) and handle every PDF task from ...